Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Almost 400 Surgeons Register for Integra LifeSciences Workshops at the American Society for Surgery of the Hand (ASSH) Annual Meeting
PLAINSBORO, N.J., Oct. 5, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) will offer four workshops at the 65 th Annual Meeting of the American Society for Surgery of the Hand (ASSH) on October 7-9 in Boston, Massachusetts.
View HTML
Toggle Summary Court Upholds Integra LifeSciences Patents
Court Upholds Integra LifeSciences Patents Finding of Infringement by Merck KGaA upheld; Case Remanded For New Damages Calculation Plainsboro, NJ /June 9, 2003 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the United States Court of Appeals for the Federal
View HTML
Toggle Summary District Court Awards Integra LifeSciences $6.37 Million in Damages
District Court Awards Integra LifeSciences $6.37 Million in Damages PLAINSBORO, N.J., Sept. 28, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the United States District Court for the Southern District of California, ruling in the case Integra
View HTML
Toggle Summary FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge
FDA Panel Recommends rhBMP-2 Product Including Integra LifeSciences Absorbable Collagen Sponge PLAINSBORO, N.J.--(BUSINESS WIRE)--Jan. 11, 2002--Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the Orthopedic and Rehabilitation Devices Panel of the United States Food and
View HTML
Toggle Summary Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents
Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern
View HTML
Toggle Summary Integra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries
Integra Announces Increased Use of NeuraGen Nerve Guide in Complex Peripheral Nerve Injuries PLAINSBORO, N.J., April 26, 2006 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that the NeuraGen® Nerve Guide is increasingly used in a wide variety of
View HTML
Toggle Summary Integra Announces Pricing of Convertible Senior Notes
PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a private placement solely
View HTML
Toggle Summary Integra Announces Private Placement of Convertible Senior Notes
PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016.
View HTML
Toggle Summary Integra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts
PLAINSBORO, N.J., Sep 22, 2008 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the OSVII Low Pro(TM) Valve, a low profile version of the OSVII(R) Flow-Controlled Hydrocephalus Valve.
View HTML
Toggle Summary INTEGRA Dermal Regeneration Template Launched in Japan
Receives Approval for Use in Life-Threatening Burns
View HTML